MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.3B
1-Year Return
46.22%
This Quarter Return
+21.87%
1 Year Return
+46.22%
3 Year Return
+108.24%
5 Year Return
–
10 Year Return
–
AUM
$22.1B
AUM Growth
+$6.53B
(+42%)
Cap. Flow
+$4.21B
Cap. Flow
% of AUM
19.02%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,731
New
561
Increased
342
Reduced
340
Closed
467
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$237M |
| 2 |
Apple
AAPL
|
+$235M |
| 3 |
Elevance Health
ELV
|
+$197M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$186M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$173M |
Top Sells
| 1 |
Adobe
ADBE
|
+$189M |
| 2 |
AbbVie
ABBV
|
+$166M |
| 3 |
Mercado Libre
MELI
|
+$123M |
| 4 |
Humana
HUM
|
+$119M |
| 5 |
Fidelity National Information Services
FIS
|
+$118M |
Sector Composition
| 1 | Healthcare | 27.41% |
| 2 | Technology | 18% |
| 3 | Consumer Discretionary | 12.02% |
| 4 | Financials | 8.87% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Opendoor
OPEN
$6.48B
| $659K | ﹤0.01% |
29,011
-45,846
| -61% | -$1.04M |
|
1027
Stantec
STN
$12.6B
| $657K | ﹤0.01% |
20,243
-120,527
| -86% | -$3.91M |
|
1028
AMN Healthcare
AMN
$702M
| $650K | ﹤0.01% |
+9,522
| New | +$650K |
|
1029
Bally's
BALY
$487M
| $650K | ﹤0.01% |
+12,956
| New | +$650K |
|
1030
Masco
MAS
$15.5B
| $650K | ﹤0.01% |
11,840
-37,611
| -76% | -$2.06M |
|
1031
Rithm Capital
RITM
$6.57B
| $649K | ﹤0.01% |
+65,290
| New | +$649K |
|
1032
Adeia
ADEA
$1.7B
| $634K | ﹤0.01% |
114,632
+14,148
| +14% | +$78.2K |
|
1033
Beyond Meat
BYND
$198M
| $633K | ﹤0.01% |
5,061
+2,906
| +135% | +$363K |
|
1034
LivaNova
LIVN
$3.1B
| $632K | ﹤0.01% |
9,547
-11,910
| -56% | -$788K |
|
1035
Grupo Aeroportuario del Pacifico
PAC
$12.8B
| $631K | ﹤0.01% |
5,677
+1,033
| +22% | +$115K |
|
|
CAJ
1036
DELISTED
Canon, Inc.
CAJ
| $624K | ﹤0.01% |
+32,086
| New | +$624K |
|
1037
Photronics
PLAB
$1.33B
| $620K | ﹤0.01% |
55,477
-186,426
| -77% | -$2.08M |
|
1038
Kinder Morgan
KMI
$61.5B
| $619K | ﹤0.01% |
45,273
-54,001
| -54% | -$738K |
|
1039
M/I Homes
MHO
$4.09B
| $618K | ﹤0.01% |
13,947
-104,275
| -88% | -$4.62M |
|
1040
Stride
LRN
$6.93B
| $616K | ﹤0.01% |
+29,046
| New | +$616K |
|
1041
Hawaiian Electric Industries
HE
$2.09B
| $615K | ﹤0.01% |
17,404
-75,408
| -81% | -$2.66M |
|
1042
Aligos Therapeutics
ALGS
$72M
| $611K | ﹤0.01% |
+884
| New | +$611K |
|
1043
Starwood Property Trust
STWD
$7.53B
| $609K | ﹤0.01% |
31,558
-129,940
| -80% | -$2.51M |
|
1044
Suzano
SUZ
$11.8B
| $607K | ﹤0.01% |
+54,289
| New | +$607K |
|
1045
Sphere Entertainment
SPHR
$2.03B
| $606K | ﹤0.01% |
5,768
-1,834
| -24% | -$193K |
|
1046
Alkermes
ALKS
$4.5B
| $598K | ﹤0.01% |
+30,027
| New | +$598K |
|
1047
Intercorp Financial Services
IFS
$4.66B
| $589K | ﹤0.01% |
+18,217
| New | +$589K |
|
1048
KRONOS Worldwide
KRO
$704M
| $586K | ﹤0.01% |
+39,299
| New | +$586K |
|
|
BCYC
1049
Bicycle Therapeutics
BCYC
$478M
| $585K | ﹤0.01% |
+32,567
| New | +$585K |
|
1050
Pacira BioSciences
PCRX
$1.21B
| $582K | ﹤0.01% |
+9,703
| New | +$582K |
|